Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2017/02/03 | Phase 4 | Terminated |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Bestmade Natural Products | 82969-3018 | ORAL | 6 [hp_X] in 6 [hp_X] | 1/22/2025 | |
Bestmade Natural Products | 82969-9015 | ORAL | 6 [hp_X] in 6 [hp_X] | 3/23/2025 | |
Bestmade Natural Products | 82969-3020 | ORAL | 6 [hp_X] in 6 [hp_X] | 1/22/2025 | |
Bestmade Natural Products | 82969-8015 | ORAL | 6 [hp_X] in 6 [hp_X] | 3/23/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
XIAO FENG WAN | 399358 | Medicine | A | 11/13/2022 | |
Huanglian Shangqing Tablets | 401372 | Well Herb Pty Ltd | Medicine | A | 12/20/2022 |
Huang Lian Shang Qing Pian | 345124 | Medicine | A | 9/30/2020 | |
Mysekyo Australia Joint & Bone | 290462 | Medicine | A | 6/20/2017 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
CALCAREA SULPHURICA | boericke and tafel inc. | 02232107 | Tablet
,
Globules - Sublingual | 6 X | 3/1/1998 |
CALCAREA SULF GLOBULE 2CH-30CH | boiron laboratoires | 00671436 | Tablet - Oral | 2 CH / CH | 12/31/1986 |
S3 CALCAREA SULPHURICA 12X TAB | dr reckeweg canada | 02075210 | Tablet - Oral | 12 X / TAB | 12/31/1994 |
CALC SULPH PWR 6X | koegler laboratories inc. | 00858722 | Powder - Oral | 6 X / X | 12/31/1989 |
CALCAREA SULFURICA | dolisos canada inc. | 02234378 | Tablet
,
Globules
,
Liquid
,
Granules - Oral | 1 X | 1/5/1998 |
CALC SULPH 6X TAB | standard homeopathic international co | 00643335 | Tablet - Oral | 6 X / TAB | 12/31/1985 |
THC NO. 113 | total health centre | 02008319 | Drops - Oral | 30 C / ML | 12/31/1994 |
MELANGE | seroyal international inc. | 02233170 | Tablet
,
Liquid
,
Granules
,
Drops
,
Pellet
,
Globules - Oral | 1 X | 4/6/1998 |
GILBERTS BIO MINERAL H4 | biocentre | 00636231 | Tablet - Oral | 6 X / TAB | 12/31/1984 |
NOVA 7032 - LIQ | nova homeopathic therapeutics inc. | 02121255 | Liquid - Oral | 8 X / ML | 2/21/1995 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.